Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

211 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patient suffering a Transient Ischemic Attack (TIA) or stroke are subsequently at high risk of a new stroke, however, poor adherence to secondary prevention medications occurs frequently within this patient group. The purpose of this study is to evaluate whether a complex tailored pharmacist intervention will lead to increased adherence to secondary stroke prevention medications and less new stroke events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack

NCT02089074

Ischemic Attack, Transient Stroke

COMPLETED NA

Tailored Intervention to Improve Medication Adherence in Patients With Hypertension

NCT01742923

Hypertension

COMPLETED NA

:Effects of Pharmaceutical Care in Stroke Patients

NCT06129318

Stroke

COMPLETED NA

A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction

NCT03621111

Myocardial Infarction, Acute ST Segment Elevation Myocardial Infarction Non-ST Elevation Myocardial Infarction (nSTEMI)

UNKNOWN NA

An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia

NCT01504672

Cognitive Impairment

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Transient Ischemic Attack

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Complex tailored intervention

The intervention consists of 3 elements:

1. Medication review with recommendations focused on antithrombotics and adherence to guidelines and patient´s adherence to medications.
2. Discharge consultation with an pharmacist using motivational interviewing techniques.
3. Follow-up telephone calls one week, two months and six months after discharge.

Group Type EXPERIMENTAL

Complex tailored intervention

Intervention Type BEHAVIORAL

Usual care

Intervention Type BEHAVIORAL

Usual care

Group Type PLACEBO_COMPARATOR

Usual care

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Complex tailored intervention

Intervention Type BEHAVIORAL

Usual care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18 years or older
* Patient admitted or receiving ambulatory treatment for an acute transient ischemic attack or ischemic stroke which has occurred within the previous 30 days.
* The patient or a carer usually dispenses the patient's medications
* Written consent

Exclusion Criteria

* Cognitive or physical impairment that would preclude comprehension of a conversation
* Terminal illness
* Lives in a care home or an institution
* Receives dose dispensed medicine from a pharmacy
* Medicine is dispensed by a nurse in the patient's home
* Correctional mental health patients

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No